HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | +50.0% | 345 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | 0.0% | 345 | 0.0% | 0.00% | – |
| Q1 2023 | $4 | -20.0% | 345 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -99.8% | 345 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 345 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 345 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -90.3% | 345 | -83.2% | 0.00% | -100.0% |
| Q4 2021 | $72,000 | -12.2% | 2,050 | -8.3% | 0.00% | 0.0% |
| Q3 2021 | $82,000 | -9.9% | 2,235 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $91,000 | +37.9% | 2,325 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $66,000 | -10.8% | 2,325 | +0.4% | 0.00% | 0.0% |
| Q4 2020 | $74,000 | +5.7% | 2,315 | +6.7% | 0.00% | 0.0% |
| Q3 2020 | $70,000 | +29.6% | 2,170 | +11.6% | 0.00% | 0.0% |
| Q2 2020 | $54,000 | +100.0% | 1,945 | +31.0% | 0.00% | – |
| Q1 2020 | $27,000 | -22.9% | 1,485 | +5.3% | 0.00% | – |
| Q4 2019 | $35,000 | +52.2% | 1,410 | +10.6% | 0.00% | – |
| Q3 2019 | $23,000 | – | 1,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
| Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
| Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
| AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
| Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
| M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
| Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
| Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
| Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |